Scientists challenge patent ban for embryonic stem cell research
Researchers and biotech firms say European court ruling will deter investors from funding new cures
Steve Connor is the Science Editor of The Independent. He has won many awards for his journalism, including five-times winner of the prestigious British science writers’ award; the David Perlman Award of the American Geophysical Union; twice commended as specialist journalist of the year in the UK Press Awards; UK health journalist of the year and a special merit award of the European School of Oncology for his investigative journalism. He has a degree in zoology from the University of Oxford and has a special interest in genetics and medical science, human evolution and origins, climate change and the environment.
Thursday 13 June 2013
Scientists and lawyers in Britain are challenging a European ban on the patenting of embryonic stem cells which they believe is blocking the development of new treatments for a range of illnesses including diabetes, heart disease and Parkinson’s.
They have been joined by a High Court judge who has asked the Court of Justice of the European Union in Luxembourg to clarify its decision to prevent the patenting of stem cell research involving the use and destruction of human embryos. Medical researchers and biotechnology firms are incensed by the European court’s ban on stem cell patents. They say it is deterring investment in Europe while scientists in Asia forge ahead with research into new medical treatments based on embryonic stem cells.
Sir Ian Wilmut, who cloned Dolly the sheep, and Professor Austin Smith of the Wellcome Trust Centre for Stem Cell Research at Cambridge University, said that banning patents has effectively removed the protection of intellectual property that is crucial for commercial investment.
Their concerns have now been voiced by Henry Carr QC, a deputy judge of the High Court, who questioned whether the European court really understood the scientific basis of its ban, which it issued last year.
The European court ruled that German scientists could not patent a technique based on human embryonic stem cells because it involved the destruction of something “capable of commencing the process of development of a human being” – in other words a human embryo.
However, Mr Carr said that the definition of a human embryo used by the court may be too broad because it included types of artificially created “embryos” that are not capable of developing into a foetus.
“Stem cells have the potential to revolutionise the treatment of human disease. Because of their capacity to differentiate into almost any type of adult cell, human stem cells open the door to a wide variety of new therapies and other medical applications,” Mr Carr said in his judgment on a patent appeal case. “However, to exclude [from patentability] processes of development which are incapable of leading to a human being does not, in my view, strike a balance at all… It is more akin to a total exclusion from patent protection of the fruits of stem cell research, to the detriment of European industry and public health.”
Professor Pete Coffey of University College London, who is conducting one of the first clinical trials of stem cells to treat progressive blindness, said the ban on patenting stem cell research could harm its future development in Britain and Europe. “It creates [funding problems for] this kind of translational research – taking ideas from the lab into the clinic,” he said.
The US Supreme Court ruled yesterday that genes extracted from the human body cannot be patented.
NFL fans were so loud during a match that their celebrations registered as a minor earthquake
Tyre firm aimed to show how their tyres would perform in ‘unexpected’ conditions
filmAs she returns to musicals in Black Nativity, the Oscar winner opens up about coming back from tragedy
TelevisionThe enduring fascination with the life of the aristocrat fugitive continues in an ITV drama. We hear from its stars
North Korea: Kim Jong Un 'sacks powerful uncle and has his aides executed'
Is this the scariest advert ever? Japanese tyre commercial comes with its own disclaimer and health warning
Lee Rigby murder trial: Police reveal dramatic new images and footage of the moments two suspects are arrested
Food poverty in UK has reached level of 'public health emergency', warn experts
Kate Moss’ Playboy cover revealed for 60th anniversary edition
- 1 John Williams' Stoner wins Waterstones Book of the Year
- 2 The hardwired difference between male and female brains could explain why men are 'better at map reading'
- 3 Is this the scariest advert ever? Japanese tyre commercial comes with its own disclaimer and health warning
- 4 Food poverty in UK has reached level of 'public health emergency', warn experts
- 5 I’m sure Kate Moss doesn't care about posing for Playboy. But I do
£35000 - £42000 per annum: Pro-Recruitment Group: Audit Senior - Birmingham We...
£15 - £17 per hour: Morgan Hunt: A Midlands based FE College have asked Morgan...
£45000 per annum + benefits: Pro-Recruitment Group: Want to continue your care...
£17 - £22 per hour: Morgan Hunt: Morgan Hunt are working with a large East Lon...